Literature DB >> 11045959

Expression and self-regulatory function of cardiac interleukin-6 during endotoxemia.

H Saito1, C Patterson, Z Hu, M S Runge, U Tipnis, M Sinha, J Papaconstantinou.   

Abstract

Interleukin (IL)-6 reportedly has negative inotropic and hypertrophic effects on the heart. Here, we describe endotoxin-induced IL-6 in the heart that has not previously been well characterized. An intraperitoneal injection of a bacterial lipopolysaccharide into C57BL/6 mice induced IL-6 mRNA in the heart more strongly than in any other tissue examined. Induction of mRNA for two proinflammatory cytokines, IL-1beta and tumor necrosis factor (TNF)-alpha, occurred rapidly before the induction of IL-6 mRNA and protein. Although stimulation of isolated rat neonatal myocardial cells with IL-1beta or TNF-alpha induced IL-6 mRNA in vitro, nonmyocardial heart cells produced higher levels of IL-6 mRNA upon stimulation with IL-1beta. In situ hybridization and immunohistochemical analyses localized the IL-6 expression primarily in nonmyocardial cells in vivo. Endotoxin-induced expression of cardiac IL-1beta, TNF-alpha, and intercellular adhesion molecule 1 was augmented in IL-6-deficient mice compared with control mice. Thus cardiac IL-6, expressed mainly by nonmyocardial cells via IL-1beta action during endotoxemia, is likely to suppress expression of proinflammatory mediators and to regulate itself via a negative feedback mechanism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11045959     DOI: 10.1152/ajpheart.2000.279.5.H2241

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  13 in total

Review 1.  Innate immunity and aging.

Authors:  Christian R Gomez; Vanessa Nomellini; Douglas E Faunce; Elizabeth J Kovacs
Journal:  Exp Gerontol       Date:  2008-06-11       Impact factor: 4.032

2.  Age-Associated Increase in Cytokine Production During Systemic Inflammation-II: The Role of IL-1β in Age-Dependent IL-6 Upregulation in Adipose Tissue.

Authors:  Marlene E Starr; Mizuki Saito; B Mark Evers; Hiroshi Saito
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-10-24       Impact factor: 6.053

3.  Phenyl-alpha-tert-butyl nitrone reverses mitochondrial decay in acute Chagas' disease.

Authors:  Jian-Jun Wen; Vandanajay Bhatia; Vsevolod L Popov; Nisha Jain Garg
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

4.  Inhibition of sarcoplasmic reticular function by chronic interleukin-6 exposure via iNOS in adult ventricular myocytes.

Authors:  Xin-Wen Yu; Qian Chen; Richard H Kennedy; Shi J Liu
Journal:  J Physiol       Date:  2005-04-21       Impact factor: 5.182

5.  Lysozyme from hen egg white ameliorates lipopolysaccharide-induced systemic inflammation in mice.

Authors:  Ayuka Tagashira; Kosuke Nishi; Takuya Sugahara
Journal:  Cytotechnology       Date:  2019-02-05       Impact factor: 2.058

Review 6.  Muscle-derived interleukin-6: possible biological effects.

Authors:  B K Pedersen; A Steensberg; P Schjerling
Journal:  J Physiol       Date:  2001-10-15       Impact factor: 5.182

7.  Lipopolysaccharide-induced pro-inflammatory cytokines in the brain of rats in the morphine-tolerant state.

Authors:  Linda Staikos; Lorenc Malellari; Sulie L Chang
Journal:  J Neuroimmune Pharmacol       Date:  2008-06-27       Impact factor: 4.147

8.  Age-associated increase in cytokine production during systemic inflammation: adipose tissue as a major source of IL-6.

Authors:  Marlene E Starr; B Mark Evers; Hiroshi Saito
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-04-17       Impact factor: 6.053

Review 9.  Sepsis in old age: review of human and animal studies.

Authors:  Marlene E Starr; Hiroshi Saito
Journal:  Aging Dis       Date:  2014-04-01       Impact factor: 6.745

10.  Decreased pulmonary extracellular superoxide dismutase during systemic inflammation.

Authors:  Junji Ueda; Marlene E Starr; Hitoshi Takahashi; Jie Du; Ling Yi Chang; James D Crapo; B Mark Evers; Hiroshi Saito
Journal:  Free Radic Biol Med       Date:  2008-06-24       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.